These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31679269)

  • 1. Prognostic Value of Ki-67/MIB-1 Expression in Meningioma Patients: A Meta-Analysis.
    Li J; Liang R; Song C; Xiang Y; Liu Y
    Crit Rev Eukaryot Gene Expr; 2019; 29(2):141-150. PubMed ID: 31679269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysis.
    Aung TM; Ngamjarus C; Proungvitaya T; Saengboonmee C; Proungvitaya S
    PLoS One; 2024; 19(5):e0303337. PubMed ID: 38758750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic role of Ki-67/MIB-1 in meningioma: A systematic review with meta-analysis.
    Liu N; Song SY; Jiang JB; Wang TJ; Yan CX
    Medicine (Baltimore); 2020 Feb; 99(9):e18644. PubMed ID: 32118704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic role of Ki-67/MIB-1 in cervical cancer: a systematic review with meta-analysis.
    Pan D; Wei K; Ling Y; Su S; Zhu M; Chen G
    Med Sci Monit; 2015 Mar; 21():882-9. PubMed ID: 25807305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of Ki-67 is a poor prognostic marker for colorectal cancer patients: a meta analysis.
    Luo ZW; Zhu MG; Zhang ZQ; Ye FJ; Huang WH; Luo XZ
    BMC Cancer; 2019 Feb; 19(1):123. PubMed ID: 30727976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved.
    Luo Y; Zhang X; Mo M; Tan Z; Huang L; Zhou H; Wang C; Wei F; Qiu X; He R; Chen G
    Medicine (Baltimore); 2016 Apr; 95(15):e3337. PubMed ID: 27082587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and clinicopathological value of Ki-67/MIB-1 expression in renal cell carcinoma: a meta-analysis based on 4579 individuals.
    Wang Z; Xie H; Guo L; Cai Q; Shang Z; Jiang N; Niu Y
    Cancer Manag Res; 2017; 9():679-689. PubMed ID: 29200888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ki-67/MIB-1 as a Prognostic Marker in Cervical Cancer - a Systematic Review with Meta-Analysis.
    Piri R; Ghaffari A; Azami-Aghdash S; Ali-Akbar YP; Saleh P; Naghavi-Behzad M
    Asian Pac J Cancer Prev; 2015; 16(16):6997-7002. PubMed ID: 26514481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Role of Ki-67/MIB-1 in Upper Urinary-Tract Urothelial Carcinomas: A Systematic Review and Meta-Analysis.
    Lei Y; Li Z; Qi L; Tong S; Li B; He W; Chen M
    J Endourol; 2015 Nov; 29(11):1302-8. PubMed ID: 26083161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ki-67 and vascular endothelial growth factor expression in intracranial meningiomas in dogs.
    Matiasek LA; Platt SR; Adams V; Scase TJ; Keys D; Miller J; Adamo F; Long S; Matiasek K
    J Vet Intern Med; 2009; 23(1):146-51. PubMed ID: 19175733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic and prognostic values of Ki-67/MIB-1 expression in thyroid cancer: a meta-analysis with 6,051 cases.
    Pan DH; Wen DY; Luo YH; Chen G; Yang H; Chen JQ; He Y
    Onco Targets Ther; 2017; 10():3261-3276. PubMed ID: 28740401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients.
    Petrelli F; Viale G; Cabiddu M; Barni S
    Breast Cancer Res Treat; 2015 Oct; 153(3):477-91. PubMed ID: 26341751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis.
    Tian Y; Ma Z; Chen Z; Li M; Wu Z; Hong M; Wang H; Svatek R; Rodriguez R; Wang Z
    PLoS One; 2016; 11(7):e0158891. PubMed ID: 27410033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki-67 is a valuable prognostic factor in gliomas: evidence from a systematic review and meta-analysis.
    Chen WJ; He DS; Tang RX; Ren FH; Chen G
    Asian Pac J Cancer Prev; 2015; 16(2):411-20. PubMed ID: 25684464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined Angiogenesis and Proliferation Markers' Expressions as Long-Term Prognostic Factors in Renal Cell Cancer.
    Virman JP; Bono P; Luukkaala TH; Sunela KL; Kujala PM; Kellokumpu-Lehtinen PL
    Clin Genitourin Cancer; 2016 Aug; 14(4):e283-9. PubMed ID: 26821530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Overexpression of Ki-67 a Prognostic Biomarker of Upper Tract Urinary Carcinoma? A Retrospective Cohort Study and Meta-Analysis.
    Fan B; Zhang H; Jin H; Gai Y; Wang H; Zong H; Jin M; Yang H; Wan S; Zhu J; Xu S; Wang J; Yang D; Song X
    Cell Physiol Biochem; 2016; 40(6):1613-1625. PubMed ID: 28006766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
    Yang C; Zou K; Zheng L; Xiong B
    BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study.
    Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV
    APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients.
    de Azambuja E; Cardoso F; de Castro G; Colozza M; Mano MS; Durbecq V; Sotiriou C; Larsimont D; Piccart-Gebhart MJ; Paesmans M
    Br J Cancer; 2007 May; 96(10):1504-13. PubMed ID: 17453008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTTG-1 (Securin) immunoexpression in meningiomas correlates with tumor grade and proliferation rate: potential use as a diagnostic marker of malignancy.
    Iliadis A; Virvili MA; Flaris NA; Pervana S; Pazarli E; Tripsianis G; Grigoriou ME; Efstratiou I; Kanakis DN
    APMIS; 2018 Apr; 126(4):295-302. PubMed ID: 29575197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.